Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 1,379

Document Document Title
WO2003104254A3
The present invention provides novel derivatives comprising compounds in the androstane and androstene series, coupled with ascorbic acid, including salts thereof, and represented by one or more of the general formulae (I), (II), (III): ...  
WO/2004/028475A2
Glycosylceramide analogues are disclosed in which the ceramide moiety and optionally the carbohydrate moiety are modified or replaced. These analogues are useful as immunomodulators, antitumor agents, and as other pharmaceutical agents.  
WO/2004/024745A2
There is provided a crystalline chemical complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline complex is of space group P212121 havi...  
WO2003043640A3
The present invention relates to a method for the treatment of a patient suffering from major depressive disorder by administering to the patient an effective amount of a glucocorticoid receptor antagonist and to methods for establishing...  
WO/2004/017904A2
The invention features corticosteroids conjugated to either a charged group or a bulky group in a manner that resists in vivo cleavage, the resulting conjugate is a peripherally acting steroid with reduced activity in the central nervous...  
WO/2004/009613A1
There is provided a crystalline chemical complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in that the crystalline complex is of space group P212121...  
WO/2004/005313A2
The present invention relates (a) to new compounds represented by Formula I wherein M represents a macrocode subunit (macrolide moiety) derived from macrolide possessing the property of accumulation in inflammatory cells, V represents an...  
WO/2003/104254A2
The present invention provides novel derivatives comprising compounds in the androstane and androstene series, coupled with ascorbic acid, including salts thereof, and represented by one or more of the general formulae (I), (II), (III): ...  
WO/2003/075931A1
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in an animal comprises administering a non-toxic and therapeutically effective amount of one or more of the following compounds: formula (I,...  
WO2003062259A3
A compound of formula (I); wherein R1 represents represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl o...  
WO/2003/066655A1
According to one aspect of the invention, there is provided a compound of formula (I) in the form of a substantially amorphous solid.  
WO/2003/066026A1
There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein: (a) a glucocorticoid of formula (I), wherein R represents ethyl or a 5 membered heterocyclic aromati...  
WO/2003/066032A1
There is provided a pharmaceutical aerosol formulation comprising (i) a compound of formula (I) or a solvate thereof as medicament, (ii) a liquified hydrofluoroalkane (HFA) gas as propellant; and characterised in that the compound of for...  
WO/2003/066036A1
According to one aspect of the invention, there is provided a pharmaceutical formulation for administration by inhalation comprising a compound of formula (I), or a solvate thereof, together with a long−acting β2−adrenoreceptor agon...  
WO/2003/066656A1
There is provided a crystalline complex comprising a compound of formula (I) in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in that the crystalline complex is of space group P212121 having u...  
WO/2003/066024A1
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.  
WO/2003/064445A1
A compound of formula (I): wherein R1 represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 5 membered heterocyclic aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl group...  
WO2003035668A3
Novel Anti-inflammatory Androstane DerivativesThere are provided compounds of formula (I) wherein R1 represents O, S or NH;R2 represents -C(=O)-aryl or -C(=O)-heteroaryl;R3 represents hydrogen, methyl (which may be in either the ( or ( c...  
WO/2003/062259A2
A compound of formula (I); wherein R1 represents represents C1-6 alkyl or C1-6 haloalkyl; R2 represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with one or more methyl o...  
WO2002038166A3
The present invention relates to methods and compositions for the use in treating type 2 diabetes and obesity. More specifically, the invention relates to the methods of screening for the active compound from berries from plants of the P...  
WO/2003/043640A2
The present invention relates to a method for the treatment of a patient suffering from major depressive disorder by administering to the patient an effective amount of a glucocorticoid receptor antagonist and to methods for establishing...  
WO/2003/035668A2
Novel Anti-inflammatory Androstane DerivativesThere are provided compounds of formula (I) wherein R1 represents O, S or NH;R2 represents -C(&equals O)-aryl or -C(&equals O)-heteroaryl;R3 represents hydrogen, methyl (which may be in eithe...  
WO2002079219A3
The present invention is based on the finding that 6-O-acyl-beta-D-glucosyl-beta-sitosterols extracted from fig latex were effective in inhibiting cell proliferation and thus may be used as anti-proliferative agents for the treatment of ...  
WO2002055529A8
A method for recovering soy saponis which comprises extracting a soy isoflavone concentrate derived from soy molasses with a mixture of acetone and water, removing undissolved solids from the extract, cooling the extract such that soy sa...  
WO/2003/022866A1
A cholesterol derivative represented by the following general formula (1), which specifically bonds to ß2−glycoprotein. By using this derivative, ß2−glycoprotein or the like can be highly practically determined. Based on this deter...  
WO2002055529A3
A method for recovering soy saponis which comprises extracting a soy isoflavone concentrate derived from soy molasses with a mixture of acetone and water, removing undissolved solids from the extract, cooling the extract such that soy sa...  
WO/2003/010182A1
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 an...  
WO/2002/100879A1
There are provided compounds of formula (I) wherein R¿1? represents C¿1-6? alkyl or C¿1-6? haloalkyl; R¿2? represents a 4-7 membered non-aromatic ring containing 1-3 heteroatoms selected from O, N and S optionally substituted with on...  
WO/2002/094284A1
22,29-epoxy-3,4,6,7,29-pentahydroxy-,(3$g(a),4$g(b),5$g(a),6 $g(a),7$g(b),14$g(b),22S)-stigmastan-15-one is useful for treating dry eye disorders and other disorders requiring the wetting of the eye.  
WO2001042273A9
This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and allevi...  
WO/2002/079219A2
The present invention is based on the finding that 6-O-acyl-beta-D-glucosyl-beta-sitosterols extracted from fig latex were effective in inhibiting cell proliferation and thus may be used as anti-proliferative agents for the treatment of ...  
WO/2002/072599A1
Efficacious intravenous preparations, skin preparations for external use, mucosal preparations for external use or cosmetics comprising novel ginsenoside derivatives (in particular, dihydroxyginsenoside Rb¿1? or epoxyginsenoside Rb¿1?)...  
WO/2002/069977A1
The invention relates to the use of compounds to treat a number of conditions, such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy. Compounds that can be used in the invention include methyl-2,3,4-trihydroxy...  
WO2001032679A9
A novel glycoside compound for use in treating or preventing cardiovascular disease and it's underlying conditions such as atherosclersis and hypercholeterolemia comprises a carbohydrate moiety and a non-carbohydrate moiety wherein the c...  
WO2002019971A9
The invention relates to 17-Methylene steroids. Method for the production thereof and pharmaceutical compositions containing these compounds. The inventive compounds have an active profile with a hybrid character of such that they act as...  
WO/2002/055529A2
A method for recovering soy saponis which comprises extracting a soy isoflavone concentrate derived from soy molasses with a mixture of acetone and water, removing undissolved solids from the extract, cooling the extract such that soy sa...  
WO/2002/055531A1
The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.  
WO2001042273A3
This invention relates to methods for treating asthma or allergy in a mammal by administering a 3-aminosteroid compound to a mammal in need thereof. The 3-aminosteroid compound being capable of down regulating the IL-9 pathway and allevi...  
WO/2002/038166A2
The present invention relates to methods and compositions for the use in treating type 2 diabetes and obesity. More specifically, the invention relates to the methods of screening for the active compound from berries from plants of the P...  
WO2002000679A3
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals.  
WO/2002/019971A1
The invention relates to 17-Methylene steroids. Method for the production thereof and pharmaceutical compositions containing these compounds. The inventive compounds have an active profile with a hybrid character of such that they act as...  
WO/2002/012266A1
There are provided according to the invention compounds of formula (I) wherein R¿1? represents C¿1-6? alkyl or C¿1-6? haloalkyl; R¿2? represents -C(=O)-aryl or -C(=O)-heteroaryl; R¿3? represents hydrogen, methyl (which may be in eit...  
WO2001030802A3
The present invention provides methods and compositions to prevent or treat a hematopoietic disorder such as thrombocytopenia or neutropenia by administering to a subject an effective amount of a steroid such as 3,7,16,17-tetrahydroxy-an...  
WO/2002/012265A1
According to one aspect of the invention, there is provided a compound of formula (I) and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.  
WO/2002/008243A1
The present invention relates inter alia to a novel oxidation process for the synthesis of a known intermediate, useful in the preparation of anti-inflammatory steroids, the known intermediate being of formula (I).  
WO/2002/000679A2
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals.  
WO/2001/098322A1
The present invention comprises the design, synthesis and development of a new class of chemotherapeutic agents for prophylactic and therapeutic treatments in a mammal, particularly a human, believed to be at risk of suffering from a hor...  
WO/2001/092289A1
Efficacious intravenous preparations, skin preparations for external use, mucosal preparations for external use or cosmetics comprising ginsenosides, in particular, ginsenoside Rb or its derivative which are useful as skin tissue regener...  
WO/2001/079256A1
A 19-norbufalin derivative compound of formula (I) and isomers pharmaceutically acceptable salts thereof. Compounds of formula (I) are Na?+¿,K?+¿-ATPase inhibitors and can be used in the treatment of cardiac and/or vascular malfunction...  
WO2001032679A3
A novel glycoside compound for use in treating or preventing cardiovascular disease and it's underlying conditions such as atherosclersis and hypercholeterolemia comprises a carbohydrate moiety and a non-carbohydrate moiety wherein the c...  

Matches 151 - 200 out of 1,379